Think.Health
Description
Think.Health is a specialized venture capital firm based in Fürstenfeldbruck, Germany, dedicated to investing in the rapidly evolving healthcare sector. Established with a clear focus, the firm positions itself as a boutique risk-taker, providing capital and strategic support to early-stage companies. Their investment thesis centers on identifying and nurturing innovative ventures within digital health, medical technology, and life sciences, aiming to drive advancements and improve patient outcomes.
The firm primarily targets early-stage opportunities, ranging from Seed to Series B rounds. Think.Health is known for its hands-on approach, leveraging its deep industry expertise and extensive network to assist portfolio companies in scaling their operations and navigating complex regulatory landscapes. They typically deploy initial checks ranging from approximately $540,000 to $5.4 million, reflecting their commitment to significant, impactful investments in promising healthcare startups. This financial commitment is often complemented by active board participation and operational guidance.
Think.Health has built a robust portfolio, having made over 20 investments in various healthcare innovations. Their strategic investments aim to foster companies that are not only technologically advanced but also possess strong market potential and a clear path to commercialization. The firm's reputation is built on its specialized focus and its ability to identify and support disruptive technologies that address critical needs in healthcare. With a strong presence in the European healthcare investment landscape, Think.Health continues to be a key player in shaping the future of health technology.
Investor Profile
Think.Health has backed more than 34 startups, with 3 new investments in the last 12 months alone. The firm has led 12 rounds, about 35% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in Germany, United States, Switzerland.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Led 2 rounds in the past year.
- Typical check size: $540K – $5.4M.
Stage Focus
- Seed (44%)
- Series A (24%)
- Series Unknown (12%)
- Series C (6%)
- Series B (6%)
- Series D (3%)
- Private Equity (3%)
- Series E (3%)
Country Focus
- Germany (79%)
- United States (15%)
- Switzerland (3%)
- France (3%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Health Diagnostics
- Mhealth
- Bioinformatics
- Fitness
- Medical
- Mental Health
- Hospitality
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
